Polycystic ovary syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Intervention group (Oral Probiotic Capsule): One probiotic capsule will be administered orally daily for one month. From the second month, ovulation-stimulating drugs will be administe
brand name LactoFem, Zist-Takhmir) contains 7 beneficial bacterial strains. Intervention 2: Control group: Ovulation-stimulating drugs will be administered from the third day of the menstrual cycle ac
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Age between 18 and 35 Informed consent Suffering from polycystic ovary syndrome IVF candidate Insensitivity to probiotics Negative male infertility factor
Exclusion criteria
Exclusion criteria: Age less than 18 years More than 35 years old Allergy to probiotics Repeated miscarriages more than 3 times The simultaneous existence of male infertility factor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chemical pregnancy rate. Timepoint: 2 weeks after IVF. Method of measurement: Measurement of serum beta HCG levels. A chemical pregnancy will be confirmed if the serum beta HCG level is above 50 IU/L.;Clinical pregnancy rate. Timepoint: 2 weeks after positive beta HCG test. Method of measurement: Clinical pregnancy will be confirmed by observing fetal heart activity via transvaginal ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactTahereh Behrouzi Lak
Oroumia University of Medical Sciences
Outcome results
None listed